Recommendations for inclusion in the Authorisation List
Nested Applications
ECHA CHEM banner at incl. authorisaton list
The information from ECHA’s recommendations for inclusion in Annex XIV is currently available in our new chemicals database, ECHA CHEM since 16 September 2025. To guarantee a smooth transition, we will also maintain the information up to date in the below list of Recommendations, for the time being.
More information on the transition to ECHA CHEM.

Recommendations for inclusion in the Authorisation List - toptext
The REACH Regulation requires that ECHA recommends from the "Candidate List" priority substances for inclusion in Annex XIV (the "Authorisation List") to the European Commission, taking into account comments received from interested parties and the opinion of the Member State Committee. The European Commission finally decides, which substances will be included in Annex XIV and what the associated entries will be.
The below table includes all Candidate List substances that have been included in ECHA's draft or final recommendations for inclusion in Annex XIV. The "Status"- column indicates whether the substances have been included in a draft recommendation, recommended for inclusion or are already included in Annex XIV. Further details and documents relevant for the recommendations can be found by clicking on the "Details" next to the substances.
Substances not recommended in a given round (Status: “Not recommended in this round”) are re-assessed in subsequent rounds along with the other substances on the Candidate List. They may be included in future recommendations. Therefore, it is advisable to search the table by substance (Name/EC/CAS) to capture the most up-to-date status.
Annex XIV recommendations dissemination list - see also
- Consultation on draft recommendation for inclusion in the Authorisation List
- MSC recommendation opinions
- Recommendation for inclusion in the Authorisation List under the Legislation section
- Authorisation Process
- Recommendation to amend authorisation list entries
- Candidate List of SVHCs for authorisation
- Authorisation List
Recommendations for inclusion in the Authorisation List
Last updated 02 February 2026. Database contains 120 unique substances/entries.
223-445-4 | 3896-11-5 | vPvB (Article 57e) | 13th recommendation | Included in draft recommendation | View Details | ||
221-573-5 | 3147-75-9 | vPvB (Article 57e) | 13th recommendation | Included in draft recommendation | View Details | ||
204-112-2 | 115-86-6 | Endocrine disrupting properties (Article 57(f) - environment) | 13th recommendation | Included in draft recommendation | View Details | ||
438-340-0 | 119344-86-4 | Toxic for reproduction (Article 57c) | 13th recommendation | Included in draft recommendation | View Details | ||
show/hide | - | - | vPvB (Article 57e) | 12th recommendation | Not recommended for inclusion in Annex XIV - to be re-assessed in following round | 18-Nov-2025 | View Details |
237-222-4 | 13701-59-2 | Toxic for reproduction (Article 57c) | 12th recommendation | Recommended for inclusion in Annex XIV | 18-Nov-2025 | View Details | |
278-355-8 | 75980-60-8 | Toxic for reproduction (Article 57c) | 12th recommendation | Recommended for inclusion in Annex XIV | 18-Nov-2025 | View Details | |
X4261 | 401-850-9 | 255881-94-8 | PBT (Article 57d) | 12th recommendation | Recommended for inclusion in Annex XIV | 18-Nov-2025 | View Details |
203-615-4 | 108-78-1 | Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) | 12th recommendation | Recommended for inclusion in Annex XIV | 18-Nov-2025 | View Details | |
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97 | 400-600-6 | 71868-10-5 | Toxic for reproduction (Article 57c) | 11th recommendation | Recommended for inclusion in Annex XIV | 12-Apr-2023 | View Details |
CG 25-369; IRGACURE 369; TK 11-319 | 404-360-3 | 119313-12-1 | Toxic for reproduction (Article 57c) | 11th recommendation | Recommended for inclusion in Annex XIV | 12-Apr-2023 | View Details |
show/hide | 799-970-2 | - | Toxic for reproduction (Article 57c) | 11th recommendation | Recommended for inclusion in Annex XIV | 12-Apr-2023 | View Details |
203-468-6 | 107-15-3 | Respiratory sensitising properties (Article 57(f) - human health) | 11th recommendation | Recommended for inclusion in Annex XIV | 12-Apr-2023 | View Details | |
203-856-5 | 111-30-8 | Respiratory sensitising properties (Article 57(f) - human health) | 11th recommendation | Recommended for inclusion in Annex XIV | 12-Apr-2023 | View Details | |
231-100-4 | 7439-92-1 | Toxic for reproduction (Article 57c) | 11th recommendation | Recommended for inclusion in Annex XIV | 12-Apr-2023 | View Details | |
show/hide | 799-969-7 | - | Toxic for reproduction (Article 57c) | 11th recommendation | Recommended for inclusion in Annex XIV | 12-Apr-2023 | View Details |
276-090-2 | 71850-09-4 | Toxic for reproduction (Article 57c) | 11th recommendation | Recommended for inclusion in Annex XIV | 12-Apr-2023 | View Details | |
208-762-8 | 540-97-6 | PBT (Article 57d) vPvB (Article 57e) | 10th recommendation | Recommended for inclusion in Annex XIV | 14-Apr-2021 | View Details | |
208-764-9 | 541-02-6 | PBT (Article 57d) vPvB (Article 57e) | 10th recommendation | Recommended for inclusion in Annex XIV | 14-Apr-2021 | View Details | |
209-136-7 | 556-67-2 | PBT (Article 57d) vPvB (Article 57e) | 10th recommendation | Recommended for inclusion in Annex XIV | 14-Apr-2021 | View Details | |
234-541-0 | 12008-41-2 | Toxic for reproduction (Article 57c) | 10th recommendation | Recommended for inclusion in Annex XIV | 14-Apr-2021 | View Details | |
209-008-0 | 552-30-7 | Respiratory sensitising properties (Article 57(f) - human health) | 10th recommendation | Recommended for inclusion in Annex XIV | 14-Apr-2021 | View Details | |
201-545-9 | 84-61-7 | Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) | 10th recommendation | Recommended for inclusion in Annex XIV | 14-Apr-2021 | View Details | |
262-967-7 | 61788-32-7 | vPvB (Article 57e) | 10th recommendation | Recommended for inclusion in Annex XIV | 14-Apr-2021 | View Details | |
covering any of its individual anti- and syn-isomers or any combination thereof show/hide | - | - | vPvB (Article 57e) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details |
209-218-2 | 561-41-1 | Carcinogenic (Article 57a) | 9th recommendation | Included in Annex XIV (Authorisation List) | 01-Oct-2019 | View Details | |
201-245-8 | 80-05-7 | Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details | |
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl) show/hide | - | - | Endocrine disrupting properties (Article 57(f) - environment) | 9th recommendation | Included in Annex XIV (Authorisation List) | 01-Oct-2019 | View Details |
915-270-3 | - | Toxic for reproduction (Article 57c) | 9th recommendation | Included in Annex XIV (Authorisation List) | 01-Oct-2019 | View Details | |
239-622-4 | 15571-58-1 | Toxic for reproduction (Article 57c) | 9th recommendation | Included in Annex XIV (Authorisation List) | 01-Oct-2019 | View Details | |
273-688-5 | 69011-06-9 | Toxic for reproduction (Article 57c) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details | |
235-702-8 | 12578-12-0 | Toxic for reproduction (Article 57c) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details | |
292-966-7 | 91031-62-8 | Toxic for reproduction (Article 57c) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details | |
234-853-7 | 12036-76-9 | Toxic for reproduction (Article 57c) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details | |
263-467-1 | 62229-08-7 | Toxic for reproduction (Article 57c) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details | |
201-075-4 | 78-00-2 | Toxic for reproduction (Article 57c) | 9th recommendation | Included in Annex XIV (Authorisation List) | 01-Oct-2019 | View Details | |
215-290-6 | 1319-46-6 | Toxic for reproduction (Article 57c) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details | |
235-252-2 | 12141-20-7 | Toxic for reproduction (Article 57c) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details | |
all possible combinations of the cis- and trans-isomers show/hide | - | - | Respiratory sensitising properties (Article 57(f) - human health) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details |
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers show/hide | - | - | Respiratory sensitising properties (Article 57(f) - human health) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details |
203-713-7 | 109-86-4 | Toxic for reproduction (Article 57c) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details | |
203-804-1 | 110-80-5 | Toxic for reproduction (Article 57c) | 9th recommendation | Recommended for inclusion in Annex XIV | 01-Oct-2019 | View Details | |
253-037-1 | 36437-37-3 | vPvB (Article 57e) | 8th recommendation | Included in Annex XIV (Authorisation List) | 05-Feb-2018 | View Details | |
247-384-8 | 25973-55-1 | PBT (Article 57d) vPvB (Article 57e) | 8th recommendation | Included in Annex XIV (Authorisation List) | 05-Feb-2018 | View Details | |
223-383-8 | 3864-99-1 | vPvB (Article 57e) | 8th recommendation | Included in Annex XIV (Authorisation List) | 05-Feb-2018 | View Details | |
223-346-6 | 3846-71-7 | PBT (Article 57d) vPvB (Article 57e) | 8th recommendation | Included in Annex XIV (Authorisation List) | 05-Feb-2018 | View Details | |
covering any of the individual stereoisomers of [1] and [2] or any combination thereof show/hide | - | - | vPvB (Article 57e) | 8th recommendation | Included in Annex XIV (Authorisation List) | 05-Feb-2018 | View Details |
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5) show/hide | - | - | Toxic for reproduction (Article 57c) | 8th recommendation | Included in Annex XIV (Authorisation List) | 05-Feb-2018 | View Details |
212-828-1 | 872-50-4 | Toxic for reproduction (Article 57c) | 8th recommendation | Recommended for inclusion in Annex XIV | 05-Feb-2018 | View Details | |
235-380-9 | 12202-17-4 | Toxic for reproduction (Article 57c) | 7th recommendation | Recommended for inclusion in Annex XIV | 10-Nov-2016 | View Details | |


